Aravis Overview

  • Investor Type
  • Growth/​Expansion

  • Status
  • Active

  • Professionals
  • 4

Professionals

  • Investments
  • 49

  • Portfolio
  • 2

  • Exits
  • 37

Exits

Aravis General Information

Company Description

Founded in 2001, Aravis is a growth and expansion firm based in Zurich, Switzerland. The firm prefers to invest in companies operating in biotech, oncology, autoimmune diseases, personalized treatments, digital healthcare, blockchain, machine learning, artificial intelligence, internet of things, virtual and augmented reality, face recognition, gaming, advanced sensors, composite materials, agricultural disruption, special situations, and smart distribution systems sectors.

Business Details

Website
www.aravis.ch
Year Founded
2001
Investor Status
Actively Seeking New Investments
Trade Association
Swiss Private Equity & Corporate Finance (SWPE)
Primary Investor Type
Growth/Expansion
Other Investor Types
Infrastructure
PE/Buyout
Venture Capital
Corporate Office
  • Merkurstrasse 70
  • 8032 Zurich
  • Switzerland
+41 043 000 00 00

Aravis Investments (49)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Bird Rock Bio 01-Oct-2016 00000 00000 000 Drug Discovery Clinical Trials - Phase 2 00000 00000 00.0
Bird Rock Bio 03-Apr-2015 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000 00000 00.0
Urogen Pharma 06-Jun-2014 00000 00000 0000 Drug Delivery Generating Revenue/Not Profitable
Synaffix 19-Feb-2014 00000 00000 Discovery Tools (Healthcare) Generating Revenue 00000 00000 00.0
Bellerophon Therapeutics 01-Feb-2014 Spin-Off 0000 Biotechnology Generating Revenue
You’re viewing 5 of 49 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aravis Exits (37)

Company Name Exit Date Exit Type Exit Size
Bird Rock Bio 18-Aug-2023 000000000000000000 000.00
Synaffix 31-May-2023 000000000000000000 00000
Light Chain Bioscience 01-Jun-2021 000000000 00000000
Marinomed Biotech 01-Feb-2019 000 000.00
Symetis 16-May-2017 Merger/Acquisition 00000
You’re viewing 5 of 37 exits. Get the full list »

Aravis Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Aravis‘s full profile, request access.

Request a free trial

Aravis Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Aravis Management, Team & Partners (32)

Name Title Deals Funds Boards Office
Claudia Zimmermann Managing Partner & Venture Partner Zurich, Switzerland
Jean-Philippe Tripet Founder & Chairman 00 0 0 Zurich, Switzerland
Léna Tripet Analyst & Assistant to CFO Zurich, Switzerland
Simon Nebel Ph.D Managing Partner & Venture Partner 0 0 0 Zurich, Switzerland
You’re viewing 4 of 32 team members. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »